Advances in upper airway diseases and allergen immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 4, 2007, Pages 872-880

  Nelson, Harold S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

allergen immunotherapy; Upper airway diseases

Indexed keywords

ALLERGEN; AMPHOTERICIN B; ANTIHISTAMINIC AGENT; CICLESONIDE; CORTICOSTEROID; DNA VACCINE; DOG DANDER EXTRACT; GRASS DANDER EXTRACT; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; OMALIZUMAB; PLACEBO; PREDNISONE; RAGWEED ANTIGEN; RESLIZUMAB; SALSOLA KALI EXTRACT; TIMOTHY GRASS EXTRACT; UNCLASSIFIED DRUG;

AIR POLLUTION; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ATOPIC DERMATITIS; BACTERIUM CONJUGATION; CELL INFILTRATION; CLINICAL TRIAL; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EAR PRURITUS; EOSINOPHIL; HAY FEVER; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INSOMNIA; MOUTH EDEMA; NONHUMAN; NOSE MUCOSA; NOSE POLYP; PARTICLE SIZE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINORRHEA; RHINOSINUSITIS; SKIN TEST; SYMPTOM; TEMPERATURE; THROAT IRRITATION; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RHINITIS; SINUSITIS;

EID: 34047108551     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.12.613     Document Type: Review

References (49)

1. Nelson H.S. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 113 (2004) 635-643
2. Nelson H.S. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 115 (2005) 676-684
3. Nelson H.S. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 117 (2006) 1047-1053
4. Bousquet J., Neukirch F., Bousquet P.J., Gehano P., Klossek J.M., Le Gal M., et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117 (2006) 158-162
5. Van Hoecke H., Vastesaeger N., Dewulf L., De Bacquer D.F., and van Cauwenberge P. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice?. J Allergy Clin Immunol 118 (2006) 758-759
6. Lockey R.F. Rhinitis medicamentosa and the stuffy nose. J Allergy Clin Immunol 118 (2006) 1017-1018
7. Greiner A.N., and Meltzer E.O. Pharmacologic rationale for treating allergic and non-allergic rhinitis. J Allergy Clin Immunol 118 (2006) 985-996
8. Passalacqua G., Bousquet P.J., Carlsen K.-H., Kemp J., Lockey R.F., Niggemann B., et al. ARIA update, I: systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 117 (2006) 1054-1062
9. Ratner P.H., Wingertzahn M.A., van Bavel J.H., Hampel F., Darken P.F., and Shah T. Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 118 (2006) 1142-1148
10. Graudenz G.S., Landgraf R.G., Jancar S., Tribess A., Fonseca S.G., Fae K.C., et al. The role of allergic rhinitis in nasal responses to sudden temperature changes. J Allergy Clin Immunol 118 (2006) 1126-1132
11. Cruz A.A., Naclerio R.M., Proud D., and Togias A. Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol 117 (2006) 1351-1358
12. Nikasinovic L., Just J., Sahraoui F., Seta N., Grimfeld A., and Momas I. Nasal inflammation and personal exposure to fine particles PM2.5 in asthmatic children. J Allergy Clin Immunol 117 (2006) 1382-1388
13. Sarin S., Undem B., Sanico A., and Togias A. The role of the nervous system in rhinitis. J Allergy Clin Immunol 118 (2006) 999-1014
14. Wu X., Myers A.C., Goldstone A.C., Togias A., and Sanico A.M. Localization of nerve growth factor and its receptors in the human nasal mucosa. J Allergy Clin Immunol 118 (2006) 428-433
15. KleinJan A., Willart M., van Rijt L.S., Braundstahl G.-J., Leman K., Jung S., et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 118 (2006) 1117-1125
16. Aoi N., Musuda T., Murakkami D., Yajima T., Mizubuchi H., Yamada H., et al. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells. J Allergy Clin Immunol 117 (2006) 1359-1366
17. Miyahara S., Miyahara N., Matsubara S., Takeda K., Koya T., and Gelfand E.W. IL-13 is essential to the late phase response in allergic rhinitis. J Allergy Clin Immunol 118 (2006) 1110-1116
18. Ciprandi G., and Cirillo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol 118 (2006) 1105-1109
19. Dworetzky M., and John T. Connell. J Allergy Clin Immunol 118 (2006) 1192-1194
20. Sahin-Yilmaz A.A., and Naclerio R.M. Nasal priming. J Allergy Clin Immunol 118 (2006) 1190-1192
21. Lombardi C., Tansini A., and Passalacqua G. Seasonal sensorineural hearing loss associated with allergic rhinitis: a case report. J Allergy Clin Immunol 117 (2006) 468-469
22. Ebbens F.A., Scadding G.K., Badia L., Hellings P.W., Jonssen M., Mullol J., et al. Amphotericin B nasal lavages: not a solution for patients suffering from chronic rhinosinusitis. J Allergy Clin Immunol 118 (2006) 1149-1156
23. Meltzer E.O., Hamilos D.L., Hadley J.A., Lanza D.C., Marple B.F., Nicklas R.A., et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114 suppl 6 (2004) 155-212
24. Meltzer E.O., Hamilos D.L., Hadley J.A., Lanza D.C., Marple B.F., and Nicklas R.A. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 118 suppl (2006) S17-S61
25. Hissaria P., Smith W., Wormald P.J., Taylor J., Vadas M., Gillis D., et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind randomized, placebo-controlled trail with evaluation of outcome measures. J Allergy Clin Immunol 118 (2006) 128-133
26. Gevaert P., Lang-Loidolt D., Lackner A., Stammberger H., Staudinger H., Van Zele T., et al. Nasal interleukin-5 levels determine the response to anti-interleukin-5 treatment in nasal polyp patients. J Allergy Clin Immunol 118 (2006) 1133-1141
27. Ying S., Meng Q., Scadding G., Parikh A., Corrigan C.J., and Lee T.H. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol 117 (2006) 312-318
28. Sacchetti M., Lambiase A., Aronni S., Griggi T., Ribatti V., Bonini S., et al. Hyperosmolar conjunctival provocation for the evaluation of nonspecific hyperreactivity in healthy patients and patients with allergy. J Allergy Clin Immunol 118 (2006) 872-877
29. Oppenheimer J., and Nelson H.S. Skin testing: a survey of allergists. Ann Allergy Asthma Immunol 96 (2006) 19-23
30. Frew A.J., Powell R.J., Corrigan C.J., and Durham S.R. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 319-325
31. Lent A., Harbeck R., Strand M., Sills M., Schmidt K., Efaw B., et al. Immunological response to administration of standardized dog allergen extract at differing doses. J Allergy Clin Immunol 118 (2006) 1249-1256
32. Roberts G., Hurley C., Turcanu V., and Lack G. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 117 (2006) 263-268
33. Niggemann B., Jacobsen L., Dreborg S., Ferdousi H.A., Halken S., Host A., et al. Five-year follow-up on the PAT study: specific immunotherapy and long term prevention of asthma in children. Allergy 61 (2006) 855-859
34. Moller C., Dreborg S., Ferdousi H.A., Halken S., Host A., Jacobsen L., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109 (2002) 251-256
35. Werfel T., Breuer K., Rueff F., Przybilla B., Worm M., Grewe M., et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61 (2006) 202-205
36. Amin H.S., Liss G.M., and Bnstein D.I. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 117 (2006) 169-175
37. Casale T.B., Busse W.W., Kline N., Ballas Z.K., Moss M.H., Townley R.G., et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 117 (2006) 134-140
38. Cox L.S., Linnemann D.L., Nolte H., Weldon D., Finegold I., and Nelson H.S. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 117 (2006) 1021-1035
39. Bordignon V., and Surastero S.E. Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 97 (2006) 158-163
40. Durham S.R., Yang W.H., Pedersen M.R., Johansen N., and Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 802-809
41. Dahl R., Kapp A., Colombo G., de Monchy J.G.R., Rak S., Emminger W., et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 118 (2006) 434-440
42. Passalacqua G., Musarra A., Pecora S., Amoroso S., Antonicelli L., Cadario G., et al. Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of a novel SLIT formulation during a Year). J Allergy Clin Immunol 117 (2006) 946-948
43. Colas C., Monzon S., Venturini M., and Lezaun A. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule. J Allergy Clin Immunol 117 (2006) 810-816
44. Garcia-Robaina J.-C., Sanchez I., de la Torre F., Fernandez-Caldas E., and Casanovas M. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J Allergy Clin Immunol 118 (2006) 1026-1032
45. Kundig T.M., Senti G., Schnetzler G., Wolf C., Vavricka B.M.P., Futurija A., et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 117 (2006) 1470-1476
46. Bauer R., Scheiblhofer S., Kern K., Gruber C., Stepanoska T., Thalhamer T., et al. Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol 118 (2006) 269-276
47. Gabler M., Scheiblhofer S., Kern K., Leitner W.W., Stoecklinger A., Hauser-Kronbrger C., et al. Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization. J Allergy Clin Immunol 118 (2006) 734-741
48. Higgins D., Rodriquez R., Milley R., Marshall J., Abate C., dela Cruz T., et al. Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1. J Allergy Clin Immunol 118 (2006) 504-510
49. Creticos P.S., Schroeder J.T., Hamilton R.G., Balcer-Whaley S.L., Khattignavong A.P., Lindblad R., et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 355 (2006) 1445-1455